Epigenetics Expert Appointed Director of Cincinnati Cancer Center
Shuk-Mei Ho, PhD, has been appointed director of the Cincinnati Cancer Center, effective June 15, 2013. The Cincinnati Cancer Center is a collaborative initiative of the University of Cincinnati, UC Health and Cincinnati Childrens Hospital Medical Center.
Ho is currently the Jacob G. Schmidlapp Chair of Environmental Health and Professor in the UC College of Medicine, a role she has held since October 2005 and will continue to fill. A recognized translational scientist, Ho is internationally known for her expertise in the role of hormones, endocrine disruptors and epigenetics in cancer development as well as gene-environment interaction cancer research.
"In addition to being a driven translational scientist, Shuk-Mei has been shown her skill as an administrative leader by aggressively growing an already successful academic department, bringing million in funds to UC, and creating research partnerships that bridge UC and Cincinnati Childrens, said Thomas Boat, MD, CCC Governing Board member and Christian R. Holmes Professor and Dean of the College of Medicine and Vice President for Health Affairs at University of Cincinnati.
Ho has recruited 21 environmental health faculty members since 2005many with a cancer research focusand secured more than $27 million for UC for research and infrastructure improvements.
The Cincinnati Cancer Center encompasses the activities of University of Cincinnati Cancer Instituteone of four institutes of UC and UC Healthand the Cancer and Blood Diseases Institute at Cincinnati Childrens.
"Weve established three initial programmatic research themes that will serve as the driving force for our work. Success of these initial programsas well as future programswill be determined by scientific excellence and emergence of productive collaborations among Cincinnati Cancer Center members, says Ho. "Im excited and honored to lead such a brilliant group of Cincinnati-based scientists as we work toward our ultimate aspiration of creating a world-class comprehensive center designated by the National Cancer Institute and leading in research innovation to eliminate cancer.
Hos appointment follows our recruitment last year of Vijaya Gandhi, PhD, MBA, as associate director for administration at the Cincinnati Cancer Center.
In Hos role as Cincinnati Cancer Center director, she will work closely with an administrative team and research program leaders to develop cross-institutional and cross-departmental research teams and to ensure alignment with the National Cancer Institutes guidelines for research programs and initiatives.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.